High Dose “HDR-Like” Prostate SBRT: PSA 10-Year Results From a Mature, Multi-Institutional Clinical Trial

High Dose “HDR-Like” Prostate SBRT: PSA 10-Year Results From a Mature, Multi-Institutional Clinical Trial

Purpose/Objective(s)Although ample intermediate-term prostate stereotactic body radiotherapy (SBRT) outcomes have been reported, 10-year results remain relatively sparse.Materials/MethodsEighteen institutions enrolled 259 low- and intermediate-risk patients. Median follow-up is 5.5 years, with 66 pa...

Full description

Bibliographic Details
Main Authors: Donald B. Fuller, Tami Crabtree, Brent L. Kane, Clinton A. Medbery, Robert Pfeffer, James R. Gray, Anuj Peddada, Trevor J. Royce, Ronald C. Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
prostate cancer
SBRT
PSA nadir
HDR
relapse free rate
CyberKnife
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.935310/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.935310/full

Similar Items